Myomo, Inc. (NYSEAMERICAN:MYO – Get Free Report) insider Micah Mitchell sold 48,000 shares of the business’s stock in a transaction on Friday, March 14th. The shares were sold at an average price of $5.16, for a total value of $247,680.00. Following the completion of the sale, the insider now owns 140,572 shares in the company, valued at $725,351.52. This represents a 25.45 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link.
Myomo Stock Up 2.4 %
MYO opened at $5.19 on Friday. Myomo, Inc. has a 12 month low of $2.51 and a 12 month high of $7.17. The firm has a market cap of $157.00 million, a P/E ratio of -22.57 and a beta of 1.68.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of the stock. Soleus Capital Management L.P. purchased a new position in shares of Myomo in the 4th quarter valued at about $5,796,000. AIGH Capital Management LLC increased its holdings in shares of Myomo by 21.7% in the 4th quarter. AIGH Capital Management LLC now owns 3,381,567 shares of the company’s stock valued at $21,777,000 after acquiring an additional 602,719 shares during the last quarter. Portolan Capital Management LLC purchased a new position in shares of Myomo in the 4th quarter valued at about $2,446,000. Manatuck Hill Partners LLC purchased a new position in shares of Myomo in the 4th quarter valued at about $1,582,000. Finally, Aristides Capital LLC purchased a new position in shares of Myomo in the 4th quarter valued at about $1,288,000. 44.99% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Get Our Latest Report on Myomo
Myomo Company Profile
Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.
Recommended Stories
- Five stocks we like better than Myomo
- High Dividend REITs: Are They an Ideal Way to Diversify?
- MarketBeat Week in Review – 03/10 – 03/14
- 10 Best Airline Stocks to Buy
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- What Makes a Stock a Good Dividend Stock?
- How Super Micro Computer Stock Is Defying the Market Sell-Off
Receive News & Ratings for Myomo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Myomo and related companies with MarketBeat.com's FREE daily email newsletter.